Infinity Pharmaceuticals Inc - Company Profile

Powered by

All the data and insights you need on Infinity Pharmaceuticals Inc in one report.

$ $295
Buy Report View Sample
  • Save hours of research time and resources with
    our up-to-date Infinity Pharmaceuticals Inc Strategy Report

  • Understand Infinity Pharmaceuticals Inc position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Infinity Pharmaceuticals Inc: Overview

Select Item

Infinity Pharmaceuticals Inc (Infinity Pharmaceuticals) is a biopharmaceutical company which discovers and develops small molecule therapeutics for the treatment of cancer. The company’s pipeline candidate: IPI-549 selectively inhibits PI3K-gamma to reprogram tumor-associated macrophages and transforms immuno-oncology approach. The company is evaluating IPI-549 as a monotherapy and in a combination therapy in various clinical trials for the treatment of various indications such advanced solid tumors, non-small cell lung cancer (NSCLC), melanoma, squamous cell carcinoma of the head and neck (SCCHN), triple negative breast cancer (TNBC), mesothelioma and myeloid-derived suppressor cells (MDSC). The company has collaborations with other biopharmaceuticals companies for the development of its pipeline programs. Infinity Pharmaceuticals is headquartered in Cambridge, Massachusetts, the US.

 Gain a 360-degree view of Infinity Pharmaceuticals Inc and make more informed decisions for your business Gain a 360-degree view of Infinity Pharmaceuticals Inc and make more informed decisions for your business Find out more
Headquarters United States of America
Address 1100 Massachusetts Avenue, Floor 4, Cambridge, 02138
Website www.infi.com
Telephone 1 617 4531000
No of Employees 30
Industry Pharmaceuticals and Healthcare
Ticker Symbol & Exchange INFIQ (OTC)
Revenue (2021) $2.6M 39.6% (2021 vs 2020)
EPS XYZ
Net Income (2021) XYZ 2% (2021 vs 2020)
Market Cap* $10,000
Net Profit Margin (2021) XYZ 29.8% (2021 vs 2020)
* As of and is in US$
View Infinity Pharmaceuticals Inc financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Infinity Pharmaceuticals Inc premium industry data and analytics

50+

Clinical Trials

Determine Infinity Pharmaceuticals Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

20+

Catalyst Calendar

Proactively evaluate Infinity Pharmaceuticals Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

11+

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

8

Pipeline Drugs

Identify which of Infinity Pharmaceuticals Inc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

1

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

Products and Services

Products
Pipeline -
IPI-549:
Solid Tumors
XYZ
XYZ
XYZ
Understand Infinity Pharmaceuticals Inc portfolio and identify potential areas for collaboration Understand Infinity Pharmaceuticals Inc portfolio and identify potential areas for collaboration Find out more

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2023 Bankruptcy Filing In October, the company filed for Chapter 11 bankruptcy.
2023 Others In July, the company terminated its merger agreement with MEI Pharma, Inc.
2023 Contracts/Agreements In February, the company entered into an agreement to merge with MEI Pharma Inc.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Find out more
Image for loader

Competitor Comparison

Key Parameters Infinity Pharmaceuticals Inc Eisai Co Ltd Incyte Corp Seagen Inc Deciphera Pharmaceuticals Inc
Headquarters United States of America Japan United States of America United States of America United States of America
City Cambridge Bunkyo-Ku Wilmington Bothell Waltham
State/Province Massachusetts Tokyo Delaware Washington Massachusetts
No. of Employees 30 11,076 2,524 3,256 355
Entity Type Public Public Public Private Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Adelene Q. Perkins Chief Executive Officer; Chairperson Executive Board 2012 63
Robert Ilaria, M.D. Chief Medical Officer Senior Management 2021 62
Stephan Peluso Chief Scientific Officer Senior Management 2021 53
Seth Tasker General Counsel; Senior Vice President; Secretary; Chief - Business Officer Senior Management 2019 44
Lawrence E. Bloch, M.D. President; Treasurer Senior Management 2017 57
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Infinity Pharmaceuticals Inc key executives to enhance your sales strategy Gain insight into Infinity Pharmaceuticals Inc key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward